Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 802 results for "iibs"

The Medicines Company's Kengreal gets FDA approval for coronary angioplasty adjunctive therapy
Proactive Investors USA

Medicines Company receives FDA approval for new PCI therapy

The Medicines Company, a biopharmaceutical company, has received the FDA approval for KENGREAL, or cangrelor, as an adjunctive therapy to percutaneous coronary intervention, or PCI, for reducing periprocedural thrombotic events in patients who have ... Individual.com, 1 day ago
[x]  

60 images for iibs

Pharma Letter, 1 day ago
Invest In Brussels, 1 day ago
Ipsearch.com, 1 day ago
European Pharmaceutical Review, 1 day ago
Invest In Brussels, 4 days ago
TheStreet.com, 3 days ago
TheStreet.com, 3 days ago
TheStreet.com, 3 days ago
MDLinx, 3 days ago
Institute of International Bankers, 1 week ago
TheStreet.com

Wuzhou Zhongheng Invests $52 Million in Israel's Oramed Pharma

Wuzhou Zhongheng Group paid $52 million for a 10% stake in Oramed Pharma and China rights to its two diabetes treatments. Oramed, based in Israel, develops oral versions of injected protein drugs. Details of the deal were not disclosed. In December ...
 Financial Content7 hours ago Oramed begins patient enrollment in Phase IIb oral insulin trial of ORMD-0801  Pharmaceutical Business Review2 days ago Oramed Pharmaceuticals Inc. (ORMP) Enrolls First Patient In Its Phase Ilb Oral Insulin Study 6/30/2015  ClinicSpace3 days ago Oramed Pharmaceuticals submits study protocol to FDA for Phase IIb trial of ORMD-0801  News-Medical.Net3 days ago
[x]  
SleekMoney

Trevena Downgraded by Zacks to Hold (TRVN)

Zacks cut shares of Trevena (NASDAQ:TRVN) from a buy rating to a hold rating in a research report sent to investors on Friday morning, ARN reports. According to Zacks, Trevena, Inc. is a biopharmaceutical company. It focuses on discovering and ...
 SleekMoney8 hours ago PRA Health Sciences's Hold Rating Reaffirmed at KeyBanc (PRAH)  SleekMoney12 hours ago Cytokinetics Downgraded by Zacks to Strong Sell (CYTK)  SleekMoney2 days ago PRA Health Sciences Now Covered by Analysts at KeyBanc (PRAH)  SleekMoney2 days ago

Spinifex Pharmaceuticals sold to Novartis

3-Jul-2015 Finance | Research Spinifex Pharmaceuticals and its Australian subsidiary, Spinifex Pharmaceuticals, a company focused on the development of new drugs for the treatment of chronic pain, has agreed to the sale of Spinifex to ...
 Manufacturing Chemist13 hours ago Novartis to buy pain specialist Spinifex  Pharma Field4 days ago Spinifex Pharmaceuticals to be acquired by Novartis  Center Watch4 days ago Novartis shells out $200M-plus for Spinifex and its mid-stage pain drug  FiercePharmaMarketing4 days ago

Teva announces encouraging data from Phase IIb migrane analyses

Teva Pharmaceutical Industries Ltd., a manufacturer of generic pharmaceuticals, has announced encouraging data from additional analyses of its Phase IIb studies in migraine prevention on efficacy and speed of onset of two distinct doses of ...
 Individual.com13 hours ago Acorda announces encouraging data from Phase IIb Parkinson's disease trial  Individual.com1 week ago Acorda announces favorable data from Phase IIb Parkinson's disease trial  Individual.com1 week ago

SteadyMed and Cardiome Enter into a License Agreement for the Commercialization Rights to Trevyent® Outside the U.S.

er, BC, July 3, 2015--(T-Net)--SteadyMed Ltd. (STDY), a specialty pharmaceutical company focused on the development of drug products to treat orphan and high value diseases with unmet parenteral delivery needs, and Cardiome Pharma Corp. (Nasdaq: ...
 BC Technology14 hours ago
[x]  
SleekMoney

Brokerages Set Flexion Therapeutics PT at $34.36 (NASDAQ:FLXN)

Shares of Flexion Therapeutics (NASDAQ:FLXN) have earned an average recommendation of Buy from the eight ratings firms that are presently covering the stock, Analyst Ratings.Net reports . Seven analysts have rated the stock with a buy rating. The ...
 SleekMoney15 hours ago Sarepta Therapeutics Receives Average Recommendation of Buy from Analysts (NASDAQ:SRPT)  SleekMoney5 days ago
Pharma Letter

Teva, Xenon Pain Drug Fails Phase IIb Study, Xenon Slumps

Teva Pharmaceutical Industries Limited ( TEVA - Analyst Report ) and Xenon Pharmaceuticals Inc. ( XENE - Snapshot Report ) reported disappointing top-line results from a phase IIb study on their pain management candidate, TV-45070 (4% and 8% w/w ...
 Zacks.com1 day ago Xenon and Teva's arthritic knee pain drug fails in Phase IIb trial  Pharma Letter1 day ago Xenon Pharmaceuticals Inc. To Host Conference Call And Webcast Today At 9:00 A.M. Eastern Time To Discuss TV-45070 Phase IIb Study In Osteoarthritis Pain  BioSpace2 days ago Xenon's Teva-partnered pain drug flunks a test in osteoarthritis  FierceBiotech2 days ago
[x]  

Investment Analysts Recent Ratings Updates for Avalanche Biotechnologies (AAVL)

A number of firms have modified their ratings and price targets on shares of Avalanche Biotechnologies (NASDAQ: AAVL) recently: 7/1/2015 Avalanche Biotechnologies was upgraded by analysts at Zacks from a hold rating to a buy rating. They now ...
 SleekMoney18 hours ago Investment Analysts Weekly Ratings Updates for Avalanche Biotechnologies (AAVL)  Ticker Report1 week ago Avalanche Bio Downgraded At William Blair, Firm Says Phase IIb 'A Ways Away'  Benzinga.com2 weeks ago

TiGenix: Communication en rapport avec les obligations convertibles arrivant à échéance en 2018

NOTIFICATION LA PRESENTE ANNONCE N'EST PAS DESTINEE A ETRE COMMUNIQUEE, PUBLIEE OU DISTRIBUEE, DIRECTEMENT OU INDIRECTEMENT, AUX OU VERS LES ETATS-UNIS, L'AUSTRALIE, LE CANADA, LE JAPON OU DANS TOUT AUTRE TERRITOIRE OU UNE TELLE COMMUNICATION ...
 Sante Log1 day ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less